Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...

Seizures of potentially dangerous weight loss drugs being sold on the black market in Scotland have soared as online dealers ...

Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss ...

Ready to transform your body? It's possible with this program's personalized care, telehealth consultations, and semaglutide ...

Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.

GLP-1 medicines can be helpful tools for the treatment of obesity and for other important health goals, but they’re not for everyone. Here are common reasons they may not be the right choice for you.

Novo Nordisk, a leading global healthcare company, has announced the signing of a MoU with Lifera, a biopharmaceutical ...

Eli Lilly, the maker of the diabetes drug Mounjaro and weight loss drug Zepbound ... errors associated with compounded semaglutide products, and some medical societies urge caution.

That’s not all. Though these symptoms aren’t necessarily specific to taking semaglutide (it can happen with any case of rapid weight loss), people using the drug have also coined the term ...

A U.S. study of over 500 youth aged 14–24 found high awareness but widespread hesitation about using semaglutide for weight ...